Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 11/2012

01-11-2012 | Review

Hot topics in cardiology: data from IABP-SHOCK II, TRILOGY-ACS, WOEST, ALTIDUDE, FAME II and more

Authors: Christian Ukena, Michael Böhm, Stephan H. Schirmer

Published in: Clinical Research in Cardiology | Issue 11/2012

Login to get access

Abstract

This summary article provides an update on novel clinical trials in the field of cardiovascular medicine which were presented at the annual meeting of the European Cardiac Society, held in Munich, Germany, in August 2012. The data were presented by leading experts in the field with relevant positions in the trials and registries. Unpublished reports should be considered as preliminary data as the analysis may change in the final publications. This article provides the reader with comprehensive summaries of the most recent diagnostic and therapeutic developments in cardiovascular medicine as previously reported (Walenta et al. in Clin Res Cardiol 100:955–971, 2011; Schirmer et al. in Clin Res Cardiol 98:691–699, 2009).
Literature
1.
Walenta K, Sinning JM, Werner C, Böhm M (2011) Hotline update of clinical trials and registries presented at the at the European Society of Cardiology Congress in Paris 2011. Clin Res Cardiol 100:955–971PubMedCrossRef
2.
Schirmer SH, van der Laan AM, Böhm M, Mahfoud F (2009) Hotlines and clinical trial updates presented at the European Society of Cardiology Meeting 2009: data from RE-LY, PLATO, MADIT-CRT, PROTECT, SYNTAX. TRITON and more. Clin Res Cardiol 98:691–699PubMedCrossRef
3.
Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:24–213CrossRef
4.
Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK, van Mieghem C et al (2012) Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 308:1237–1245
5.
Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K et al (2011) Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 365:2255–2267PubMedCrossRef
6.
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP et al (2012) Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 366:1404–1413PubMedCrossRef
7.
Scirica BM, Bonaca MP, Braunwald E, De Ferrari GM, Isaza D, Lewis BS et al (2012) Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial. Lancet
8.
Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT et al (2009) A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30:459–468PubMedCrossRef
9.
Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J et al (2012) Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. NEJM
10.
Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R et al (2012) Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet
11.
Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406PubMedCrossRef
12.
Puymirat E, STSP et al (2012) Association of changes in clinical characteristics and management with improvement in survival among patients with st-elevation myocardial infarction. JAMA 1–8
13.
Bosch J, Gerstein HC, Dagenais GR, Diaz R, Dyal L, Jung H et al (2012) n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367:309–318PubMedCrossRef
14.
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al (2009) Dabigatran versus Warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151PubMedCrossRef
15.
Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M et al (2012) Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. doi:10.​1093/​eurheartj/​ehs274
16.
Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J et al (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715PubMedCrossRef
17.
Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875–885PubMedCrossRef
18.
Borer JS, Böhm M, Ford I, Komajda M, Tavazzi L, Sendon JL et al (2012) Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. Eur Heart J. doi:10.​1093/​eurheartj/​ehs259
19.
Reil JC, Custodis F, Swedberg K, Komajda M, Borer JS, Ford I et al (2011) Heart rate reduction in cardiovascular disease and therapy. Clin Res Cardiol 100:11–19PubMedCrossRef
20.
Diener HC, Sacco R, Yusuf S (2007) Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 23:368–380PubMedCrossRef
21.
Böhm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R et al (2012) Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J. doi:10.​1093/​eurheartj/​ehs250
22.
Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kaab S et al (2012) Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J. doi:10.​1093/​eurheartj/​ehs289
23.
Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C et al (2012) Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 366:9–19PubMedCrossRef
24.
Aoki T, Fukumoto Y, Yasuda S, Sakata Y, Ito K, Takahashi J et al (2012) The Great East Japan Earthquake Disaster and cardiovascular diseases. Eur Heart J. doi:10.​1093/​eurheartj/​ehs288
25.
Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213–224PubMedCrossRef
26.
De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z et al (2012) Fractional Flow Reserve-Guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001
Metadata
Title
Hot topics in cardiology: data from IABP-SHOCK II, TRILOGY-ACS, WOEST, ALTIDUDE, FAME II and more
Authors
Christian Ukena
Michael Böhm
Stephan H. Schirmer
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Clinical Research in Cardiology / Issue 11/2012
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-012-0511-8

Other articles of this Issue 11/2012

Clinical Research in Cardiology 11/2012 Go to the issue

Original Paper

Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials

Original Paper

Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography

Original Paper

The patient’s interpretation of myocardial infarction symptoms and its role in the decision process to seek treatment: the MONICA/KORA Myocardial Infarction Registry

Original Paper

Assessment of an asymmetrical coating stent with sirolimus released from ablumial matrix in porcine model

Original Paper

Effect of transcatheter aortic valve implantation on the ascending aorta’s elasticity

Letter to the Editors

Fatal stress-induced cardiomyopathy in a young patient treated with adrenomimetics

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits